(Q37311440)

19 August 2017

1 reference

title

Resistant hypertension and hyperaldosteronism (English)

1 reference

19 August 2017

main subject

arterial hypertension

0 references

author name string

Carolina C Gonzaga

series ordinal

1

1 reference

19 August 2017

David A Calhoun

series ordinal

2

1 reference

19 August 2017

publication date

1 December 2008

1 reference

Current Hypertension Reports

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

496-503

1 reference

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0092-0

Aldosterone induces a vascular inflammatory phenotype in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0092-0

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0092-0

Primary aldosteronism: factors associated with normalization of blood pressure after surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0092-0

Aldosterone and vascular inflammation

21 January 2018

1 reference

12 December 2020

Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy.

1 reference

12 December 2020

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

1 reference

12 December 2020

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

1 reference

12 December 2020

Hyperaldosteronism among black and white subjects with resistant hypertension

1 reference

12 December 2020

Screening, treatment, and control of hypertension in US private physician offices, 2003-2004

1 reference

12 December 2020

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

1 reference

12 December 2020

Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study

1 reference

12 December 2020

Resistant hypertension: comparing hemodynamic management to specialist care.

1 reference

12 December 2020

Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

1 reference

12 December 2020

Primary aldosteronism. Diagnostic evaluation

1 reference

12 December 2020

Mineralocorticoid excess, dietary sodium, and myocardial fibrosis

1 reference

12 December 2020

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

1 reference

12 December 2020

Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region.

1 reference

12 December 2020

Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome

1 reference

12 December 2020

Efficacy of low-dose spironolactone in subjects with resistant hypertension

1 reference

12 December 2020

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

1 reference

12 December 2020

Low-renin status in therapy-resistant hypertension: a clue to efficient treatment

1 reference

12 December 2020

Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism

1 reference

12 December 2020

Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism

1 reference

12 December 2020

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

12 December 2020

Prospective study of the association between sleep-disordered breathing and hypertension

1 reference

12 December 2020

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study

1 reference

12 December 2020

Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers

1 reference

12 December 2020

Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma

1 reference

12 December 2020

Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea

1 reference

12 December 2020

Primary aldosteronism: diagnostic and treatment strategies

1 reference

12 December 2020

Primary aldosteronism and hypertensive disease

1 reference

12 December 2020

The role of spironolactone in the treatment of patients with refractory hypertension

1 reference

12 December 2020

Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure

1 reference

12 December 2020

Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension

1 reference

12 December 2020

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients

1 reference

12 December 2020

Aldosterone excess and resistance to 24-h blood pressure control

1 reference

12 December 2020

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial

1 reference

12 December 2020

High incidence of primary aldosteronism in 199 patients referred with hypertension

1 reference

12 December 2020

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients

1 reference

12 December 2020

Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004.

1 reference

12 December 2020

Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension

1 reference

12 December 2020

Atherosclerotic renal artery stenosis: overtreated but underrated?

1 reference

12 December 2020

Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients

1 reference

12 December 2020

Is there an unrecognized epidemic of primary aldosteronism? Pro.

1 reference

12 December 2020

Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample

1 reference

12 December 2020

Effect of spironolactone on blood pressure in subjects with resistant hypertension

1 reference

12 December 2020

10.1007/S11906-008-0092-0

Identifiers

DOI

1 reference

19 August 2017

1 reference